Low response rate to ATG ‐based immunosuppressive therapy in very severe aplastic anaemia – a Swedish nationwide cohort study

ConclusionsReal‐world VSAA patients respond poorly to ATG which indicates the need for a different treatment approach. Our findings suggest that age alone should not be a discriminating factor for administering ATG treatment.This article is protected by copyright. All rights reserved.

Source: European Journal of Haematology - March 12, 2018 Category: Hematology Authors: Krista Vaht, Magnus G öransson, Kristina Carlson, Cecilia Isaksson, Stig Lenhoff, Anna Sandstedt, Bertil Uggla, Jacek Winiarski, Per Ljungman, Mats Brune, Per‐Ola Andersson Tags: Original Article Source Type: research